International GrowthThe company experienced significant growth in international activity, which increased by 12.5%.
Market StrategyAnalyst's recommendation is a BUY, with a target price offering significant upside to current prices, supported by strategic initiatives and growth potential in key markets.
Product PerformanceThe latest product, Sidevit® B12, had a strong start, generating €1.1m in revenue and increasing market share to over 2% in six months.